Novartis CEO, Vas Narasimhan shares the Company’s strategy and growth update at the annual J.P. Morgan Healthcare Conference 2024.
This investor focussed presentation covers our,
- Renewed focused strategy, as an innovative medicines company, centered around core therapeutic areas and technology platforms
- Robust pipeline, streamlined in areas of high unmet need
- Attractive growth prospects, including 2023 guidance raised 3 times
- Leadership in ESG, with focus on creating value in innovation and access to medicines. an ESG leadership.
J.P. Morgan Healthcare Conference
Event Date: January 08, 2024
Novartis JPM HC 2024 Coverage: go.novartis.social/48vH5nQ
Investor Relations: go.novartis.social/3NZQpId
Investor Events: go.novartis.social/4aSWlwu
Novartis Strategy: go.novartis.social/3vur6rn
Disclaimer: J.P. Morgan Healthcare Conference live event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: go.novartis.social/3O1KKkX
Learn more: https: go.novartis.social/48vH5nQ